Histone deacetylase inhibitor entinostat in combination with a retinoid downregulates HER2 and reduces the tumor initiating cell population in aromatase inhibitor-resistant breast cancer

Addition of all-trans-retinoic acid to omeprazole and sucralfate therapy improves the prognosis of gastric dysplasia

(2015) Jianjun Jin et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Biomarker changes associated with the development of resistance to aromatase inhibitors (AIs) in estrogen receptor-positive breast cancer

(2014) M. Arnedos et al.   ANNALS OF ONCOLOGY

Targeting of preexisting and induced breast cancer stem cells with trastuzumab and trastuzumab emtansine (T-DM1)

(2014) J Diessner et al.   Cell Death & Disease

Effect of selumetinib on the growth of anastrozole-resistant tumors

(2013) Gauri J. Sabnis et al.   BREAST CANCER RESEARCH AND TREATMENT

HER2 Drives Luminal Breast Cancer Stem Cells in the Absence of HER2 Amplification: Implications for Efficacy of Adjuvant Trastuzumab

(2013) S. Ithimakin et al.   CANCER RESEARCH

Zoledronic Acid Reverses the Epithelial-Mesenchymal Transition and Inhibits Self-Renewal of Breast Cancer Cells through Inactivation of NF- B

(2013) A. J. Schech et al.   MOLECULAR CANCER THERAPEUTICS

HDAC Inhibitor Entinostat Restores Responsiveness of Letrozole-Resistant MCF-7Ca Xenografts to Aromatase Inhibitors through Modulation of Her-2

(2013) G. J. Sabnis et al.   MOLECULAR CANCER THERAPEUTICS

Epigenetic Priming of AML Blasts for All-trans Retinoic Acid-Induced Differentiation by the HDAC Class-I Selective Inhibitor Entinostat

(2013) Nadja Blagitko-Dorfs et al.   PLoS One

Identification of FDA-approved Drugs Targeting Breast Cancer Stem Cells Along With Biomarkers of Sensitivity

(2013) Poornima Bhat-Nakshatri et al.   Scientific Reports

The importance of HER2 signaling in the tumor-initiating cell population in aromatase inhibitor-resistant breast cancer

(2012) Rabia A. Gilani et al.   BREAST CANCER RESEARCH AND TREATMENT

Zoledronic acid inhibits aromatase activity and phosphorylation: Potential mechanism for additive zoledronic acid and letrozole drug interaction

(2012) Amanda J. Schech et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumours

(2011) R Pili et al.   BRITISH JOURNAL OF CANCER

Side-population cells in luminal-type breast cancer have tumour-initiating cell properties and are regulated by HER2 expression and signalling

(2010) T Nakanishi et al.   BRITISH JOURNAL OF CANCER

Trastuzumab Reverses Letrozole Resistance and Amplifies the Sensitivity of Breast Cancer Cells to Estrogen

(2009) Gauri Sabnis et al.   CANCER RESEARCH

HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion

(2008) H Korkaya et al.   ONCOGENE